Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.34
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.28% | -1.09% | -3.78% | -2.46% | 0.67% |
| Total Other Revenue | -10.66% | 13.69% | -12.74% | -12.74% | -2.87% |
| Total Revenue | 1.25% | -1.05% | -3.81% | -2.50% | 0.66% |
| Cost of Revenue | 1.68% | 0.76% | -1.01% | 0.09% | 3.26% |
| Gross Profit | -0.86% | -9.43% | -16.15% | -13.67% | -10.41% |
| SG&A Expenses | 3.11% | -4.42% | -10.53% | -7.54% | -9.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1,036.96% | 407.88% | 349.88% | 1,510.12% | -800.76% |
| Total Operating Expenses | 1.97% | 0.57% | -1.79% | -0.65% | 1.66% |
| Operating Income | -11.34% | -26.78% | -33.44% | -29.45% | -14.06% |
| Income Before Tax | -13.84% | -28.22% | -35.80% | -31.26% | -20.47% |
| Income Tax Expenses | -9.65% | -30.51% | -37.67% | -30.61% | -14.01% |
| Earnings from Continuing Operations | -14.70% | -27.77% | -35.42% | -31.39% | -21.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.61% | 49.73% | 41.64% | 20.47% | 10.43% |
| Net Income | -13.38% | -26.54% | -35.09% | -31.93% | -22.24% |
| EBIT | -11.34% | -26.78% | -33.44% | -29.45% | -14.06% |
| EBITDA | -11.10% | -23.67% | -29.96% | -25.66% | -11.06% |
| EPS Basic | -13.39% | -26.51% | -35.08% | -31.95% | -22.25% |
| Normalized Basic EPS | -7.01% | -26.55% | -32.20% | -28.86% | -21.50% |
| EPS Diluted | -13.39% | -26.51% | -35.08% | -31.95% | -22.25% |
| Normalized Diluted EPS | -7.01% | -26.55% | -32.20% | -28.86% | -21.50% |
| Average Basic Shares Outstanding | 0.01% | 0.00% | 0.01% | 0.02% | -0.01% |
| Average Diluted Shares Outstanding | 0.01% | 0.00% | 0.01% | 0.02% | -0.01% |
| Dividend Per Share | -30.21% | -30.21% | 6.85% | 6.85% | 54.27% |
| Payout Ratio | 0.65% | 0.57% | 1.23% | 1.10% | 0.33% |